Company: JUPGF
Filing Date: 2025-05-02
Form Type: DRS
Source: 0001641172-25-008279
Chunk: 138

Company: ATLAS CRITICAL MINERALS Corp
Filing Date: 2025-05-02
Form: DRS
Chunk 138
---
 A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022 (the “Representative”),
and Banco Bradesco BBI S.A., Avenida Juscelino Kubitschek, 1,309, 10th Floor, 04543-011 São Paulo, São Paulo, Brazil,
as the representatives of the underwriters, with respect to the common stock being offered. Subject to the terms and conditions
of the underwriting agreement, we have agreed to sell to the underwriters, and each of the underwriters has agreed
to purchase, at the Underwritten Offering price less the underwriting discounts set forth on the cover page of this prospectus, the number
of shares of common stock listed next to its name in the following table:

| Name of Underwriter             |     | Number of Shares |
| A.G.P./Alliance Global Partners |     |                  |
| Banco Bradesco BBI S.A.         |     |                  |
| Total                           |     |                  |

The underwriters are committed to purchase
all the shares of common stock offered by this prospectus if they purchase any shares of common stock. The underwriters are
not obligated to purchase the shares of common stock covered by the underwriters’ over-allotment option described below.
The underwriters are offering the shares of common stock, subject to prior sale, when, as and if issued to and accepted by it,
subject to approval of legal matters by their counsel, and other conditions contained in the underwriting agreement, such as the
receipt by the underwriters of officer’s certificates and legal opinions. A copy of the underwriting agreement has been
filed as an exhibit to the registration statement of which this prospectus is part. Each underwriter reserves the right to withdraw,
cancel or modify offers to the public and to reject orders in whole or in part.

Over-Allotment Option

We have granted to the underwriters an option,
exercisable no later than 45 calendar days after the date of the underwriting agreement, to purchase up to [●] additional shares
of common stock (an amount equal to 15% of the shares sold in the offering, assuming a total of [●] shares of common stock are sold at the Underwritten Offering price per share of $[●] (the midpoint of the $[●] to $[●] estimated price range of the Underwritten Offering price)), less underwriting